주식 시장 뉴스
최신 금융 뉴스 · 업데이트 5월 23, 2026
애플, 50주년: 차고 스타트업에서 3조 7,300억 달러 거물로—IPO 당시 1,000달러 투자금이 현재 얼마나 될까요?
Apple Turns 50: From Garage Startup To $3.73 Trillion Giant—Here's How Much A $1,000 Investment At Its IPO Would Be Worth Today
The panelists generally agreed that Apple's current valuation and future growth prospects are uncertain, with significant risks and opportunities ahead.
ChatGPT에게 12살 아이에게 설명하듯 이더리움을 설명해달라고 요청했습니다
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
키어 스타머, 마멀레이드? 영국에서 마멀레이드를 정말 리브랜딩해야 할까?
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
‘그레그스’가 아니네’: 틱톡 크리에이터들이 런던의 ‘젠트리피케이션된’ 제과점들을 시험대에 올리다
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
골드만삭스, PVH Corp. (PVH) 목표 주가 83달러에서 93달러로 상향
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND)는 2상 New InsiGHTS 임상시험의 52주차 긍정적인 데이터를 보고했습니다.
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research, BeOne Medicines AG (ONC)에 대한 커버리지 개시 및 아웃퍼폼 등급 부여
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
미즈호, Autolus Therapeutics plc (AUTL) 목표 주가를 12달러에서 10달러로 하향 조정
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
갈라파고스 NV (GLPG)가 Gilead와 Ouro Medicines 자산에 대한 계약을 체결했습니다.
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC, Bicycle Therapeutics plc(BCYC) 목표 주가를 11달러에서 7달러로 하향 조정
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
지금 당장 사야 할 최고의 ETF: 유가 100달러 시대
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen, Marex Group plc (MRX)에 대한 목표 주가를 61달러에서 66달러로 상향 조정
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …